Novotný Jakub, Kovaríková Petra, Novotný Michal, Janůsová Barbora, Hrabálek Alexandr, Vávrová Katerina
Centre for New Antivirals and Antineoplastics, Department of Inorganic and Organic Chemistry, Faculty of Pharmacy Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05, Hradec Králové, Czech Republic.
Pharm Res. 2009 Apr;26(4):811-21. doi: 10.1007/s11095-008-9780-3. Epub 2008 Nov 14.
Series of N,N-dimethylamino acid esters was synthesized to study their transdermal permeation-enhancing potency, biodegradability and reversibility of action. Effects of chirality, linking chain length and polyfluorination were investigated.
In vitro activities were evaluated using porcine skin and four model drugs-theophylline, hydrocortisone, adefovir and indomethacin. Biodegradability was determined using porcine esterase, reversibility was measured using electrical resistance.
No differences in activity were found between (R), (S) and racemic dodecyl 2-(dimethylamino)propanoate (DDAIP). Substitution of hydrocarbon tail by fluorocarbon one resulted in loss of activity. Replacement of branched linking chain between nitrogen and ester of DDAIP by linear one markedly improved penetration-enhancing activity with optimum in 4-6C acid derivatives. Dodecyl 6-(dimethylamino)hexanoate (DDAK) was more potent than clinically used skin absorption enhancer DDAIP for theophylline (enhancement ratio of DDAK and DDAIP was 17.3 and 5.9, respectively), hydrocortisone (43.2 and 11.5) and adefovir (13.6 and 2.8), while DDAIP was better enhancer for indomethacin (8.7 and 22.8). DDAK was rapidly metabolized by porcine esterase, and displayed low acute toxicity. Electrical resistance of DDAK-treated skin barrier promptly recovered to control values.
DDAK, highly effective, broad-spectrum, biodegradable and reversible transdermal permeation enhancer, is promising candidate for future research.
合成一系列N,N-二甲基氨基酸酯,以研究它们的透皮促渗效力、生物降解性和作用可逆性。研究了手性、连接链长度和多氟化的影响。
使用猪皮和四种模型药物——茶碱、氢化可的松、阿德福韦和吲哚美辛评估体外活性。使用猪酯酶测定生物降解性,使用电阻测量可逆性。
(R)、(S)和外消旋十二烷基2-(二甲基氨基)丙酸酯(DDAIP)之间的活性没有差异。用碳氟化合物取代烃链导致活性丧失。将DDAIP的氮和酯之间的支链连接链替换为直链连接链显著提高了促渗活性,在4-6个碳的酸衍生物中效果最佳。十二烷基6-(二甲基氨基)己酸酯(DDAK)对茶碱(DDAK和DDAIP的增强率分别为17.3和5.9)、氢化可的松(43.2和11.5)和阿德福韦(13.6和2.8)的促渗效果比临床使用的皮肤吸收促进剂DDAIP更强,而DDAIP对吲哚美辛的促渗效果更好(8.7和22.8)。DDAK可被猪酯酶快速代谢,且急性毒性较低。经DDAK处理的皮肤屏障电阻迅速恢复到对照值。
DDAK是一种高效、广谱、可生物降解且可逆的透皮促渗剂,是未来研究的有前景的候选物。